Tamiflu Adverse Event One Year Update Requested By Advisory Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Pediatric Advisory Committee agrees with FDA that neuropsychiatric events and deaths seen in pediatric patients receiving the antiviral do not represent risk signals.